Publications by authors named "Laura Gunder"

Claim this Profile
D
Dual Inhibitors of KRASG12D and HSP90 are Effective Against KRASG12D Inhibitor Resistance.
Inés Pulido, Laura C Gunder, Chenghao Ying, Yaya Wang, Yan Dai

Mol Cancer Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chaperone directed heterobifunctional molecules circumvent KRAS inhibitor resistance.
Ines Pulido, Qiyue Luan, Sara Pastor-Puente, Laura Gunder, Yaya Wang

Cancer Lett· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer.
Evan Yao, Laura Gunder, Tyra Moyer, Kristina A Matkowskyj, Kathryn Fox

Viruses· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Models of Anal Cancer Combined-Modality Therapy.
Hillary R Johnson, Laura C Gunder, Amani Gillette, Hana Sleiman, Brooks L Rademacher

J Surg Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
Laura C Gunder, Hillary R Johnson, Evan Yao, Tyra H Moyer, Heather A Green

Viruses· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.
Hillary R Johnson, Laura C Gunder, Glen E Leverson, Evie H Carchman

Dis Colon Rectum· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors.
Laura C Gunder, Tyra H Moyer, Hillary R Johnson, Andrew S Auyeung, Glen E Leverson

J Surg Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of a topical protease inhibitor, Saquinavir, to alleviate mouse papillomavirus-mediated anal disease.
Laura C Gunder, Hillary R Johnson, Heather A Green, Andrea Bilger, Tyra H Moyer

Virology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
Laura C Gunder, Simon Blaine-Sauer, Hillary R Johnson, Myeong-Kyun Shin, Andrew S Auyeung

Viruses· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/mTOR inhibition prevents anal cancer in mice with established low-grade anal dysplasia.
Laura C Gunder, Tyra H Moyer, Brooks L Rademacher, Andrew S Auyueng, Glen Leverson

Exp Mol Pathol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Delivery of a Dual PI3K/mTOR Inhibitor More Effective than Topical Delivery in Preventing Anal Carcinogenesis in an HPV Transgenic Mouse Model.
Laura C Gunder, Tyra H Moyer, Marissa R Ziolkowski, Margaret K Keating, Glen E Leverson

J Cancer Sci Clin Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity Augments Glucocorticoid-Dependent Muscle Atrophy in Male C57BL/6J Mice.
Laura C Gunder, Innocence Harvey, JeAnna R Redd, Carol S Davis, Ayat Al-Tamimi

Biomedicines· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis